Clinical trial
Velmanase alfa-EAP
Name
Velmanase alfa-EAP
Description
Individual patient expanded access requests may be considered for patients who have no other treatment options.
Trial arms
Treatment
Velmanase Alfa
Other names:
Lamzede, Lamazym, rhLAMAN, recombinant human alpha-mannosidase
Size
-1
Eligibility criteria
Inclusion Criteria:
-
Exclusion Criteria:
-
Protocol
{'studyType': 'EXPANDED_ACCESS', 'expandedAccessTypes': {'individual': True}}
Updated at
2023-09-25
1 organization
1 product
1 indication
Organization
Chiesi FarmaceuticiProduct
Velmanase AlfaIndication
alpha-mannosidosis